Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
1.
Ann Pharm Fr ; 74(3): 198-204, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26826794

RESUMEN

Cesium templated Staudinger-aza-Wittig tandem reaction (S.A.W.) has been used in the synthesis of a bis-diazacrown-bis-cellobiosyl-tetra-ureido cryptand. A novel macrotricyclic compound having a "cone-shaped" configuration was selectively obtained. Additionally, first results on potential recognition properties of the cryptand are also given.


Asunto(s)
Cesio/química , Éteres Cíclicos/química , Compuestos Policíclicos/química , Bases de Schiff/química , Tartratos/química , Compuestos Aza/química , Cationes/química , Compuestos Corona/química , Modelos Moleculares , Conformación Molecular
2.
Rev Med Suisse ; 11(456-457): 129-32, 134, 2015 Jan 14.
Artículo en Francés | MEDLINE | ID: mdl-25799669

RESUMEN

In 2014, among new therapeutic approaches in pulmonary medicine, the role of inhaled corticosteroids has to be revaluated after the publication of the WISDOM and other studies. Their prescription should no longer be systematic even for "at risk" groups of patients, as defined by the GOLD consensus, but rather be considered on an individual basis. In the field of asthma, two major studies confirm the efficacy of mepoluzimab for the treatment of severe, eosinophilic asthma. Finally, for idiopathic pulmonary fibrosis, 2014 has taught us that treatment with N-acetylcystein is of no proven benefit, while pirfenidone and nintedanib are two new drugs that may attenuate the downhill course of the disease.


Asunto(s)
Asma/tratamiento farmacológico , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Fibrosis Pulmonar/tratamiento farmacológico , Corticoesteroides/uso terapéutico , Anticuerpos Monoclonales Humanizados/uso terapéutico , Humanos , Índice de Severidad de la Enfermedad
3.
Ann Pharm Fr ; 72(6): 422-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25438653

RESUMEN

An intramolecularly promoted SAW reaction between a phosphinimide and an isocyanate intermediate led to an original bridged trisubstituted ((A,C),E)-α-cyclodextrin. The latter was in a second step converted into a new capped (ACE)-(guanidino)-α-cyclodextrin.


Asunto(s)
Guanidina/química , alfa-Ciclodextrinas/química , Hidrocarburos Aromáticos con Puentes/síntesis química , Hidrocarburos Aromáticos con Puentes/química , Dióxido de Carbono/química , Indicadores y Reactivos , Modelos Moleculares
4.
Rev Med Suisse ; 9(369): 142-6, 2013 Jan 16.
Artículo en Francés | MEDLINE | ID: mdl-23409656

RESUMEN

This review reports on papers published in 2012 that will most likely impact on daily medical practice in four different areas of pulmonary medicine. How should treatment of asthma with inhaled corticosteroids be adjusted on the long run? Should idiopathic pulmonary fibrosis receive treatment with immunosuppressive drugs? Is a long-term treatment with azithromycine for bronchiectasis supported by evidence, apart from patients with cystic fibrosis? And finally, can treatment of obstructive sleep apnea with continuous positive pressure (CPAP) prevent the occurrence of new, systemic hypertension?


Asunto(s)
Neumología/tendencias , Médicos Generales , Humanos
5.
Ann Pharm Fr ; 70(6): 360-9, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23177563

RESUMEN

Cyclodextrins (CyDs) currently displays even today the image of a natural macrocyclic compound largely dominant in the formation of inclusion complexes with small hydrophobic molecules. During the past 10years, advances in this field allowed to achieve more and more sophisticated CyDs derivatives opening a simple access in scale-up quantities to original and better CyD-based gene delivery systems. In addition, possibility to combine covalent and supramolecular approaches offers new venues for the design of tailor-made CyD-based nanovehicles to improve their transfection ability and gene transfer in cells. In this account, we describe our recent progress in the construction of a novel CyD-based G0 (generation number) core dendrimer, scalable to CyD oligomers by a strategy using protonable guanidine tethers and whose concept can be generalized for the assembly of CyD pre-coated dendrimers. The synthetic strategy based on an original Staudinger-Aza-Wittig tandem coupling reaction. We present an outline of the different analytical strategies to characterize CyD-ODN (cyclodextrin-oligodeoxynucleotide) complexes. Among them, Capillary electrophoresis (CE) was used to perfectly characterize our CyD-siRNA and CyD-DNA complexes and shown to be a very attractive method with advantages of low sample consumption, rapid analysis speed, and high efficiency that make this technology a major tool for association constant measurement. Finally, we present the different biological methods that can be used, in vitro, to study gene delivery, and more precisely ones we have performed to evaluate the capability of our original model bis-guanidinium-tetrakis-ß-cyclodextrin dendrimeric tetrapod, to deliver efficiently DNA or siRNA in eukaryotic cells.


Asunto(s)
Ciclodextrinas/química , Portadores de Fármacos/química , Técnicas de Transferencia de Gen , Secuencia de Carbohidratos , Colorantes , Ciclodextrinas/análisis , ADN/administración & dosificación , Portadores de Fármacos/análisis , Sistemas de Liberación de Medicamentos , Modelos Moleculares , Datos de Secuencia Molecular , Sales de Tetrazolio , Tiazoles
6.
Eur J Appl Physiol ; 111(7): 1507-15, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21188410

RESUMEN

The objective of this report was to analyse a potential role for FGF6 in muscle resistance to mechanical stress. Normal or regenerating muscles of FGF6 (-/-) mice versus wild-type mice were submitted to different protocols of damaging eccentric contractions (eccentric electrostimulation and intermittent downhill exercise). Then muscular structural properties were analysed by histological and immunochemistry techniques to evaluate the post-injury muscle recovery; their muscle contractile parameters (maximal tetanic force, kinetics properties and fatigue resistance) were assessed. The absence of FGF6 causes (1) a fast-to-slow myofibre type switch in adult control and regenerating Tibialis anterior (TA) muscle; (2) muscle weakness in regenerating muscles in animals submitted to eccentric exercise protocols due to aberrant extensive necrotic zones. These observations point out a crucial and unexpected role for FGF6 in muscle integrity and muscle protection against mechanical stress.


Asunto(s)
Factor 6 de Crecimiento de Fibroblastos/fisiología , Contracción Muscular/genética , Fuerza Muscular/genética , Estimulación Física , Estrés Mecánico , Animales , Factor 6 de Crecimiento de Fibroblastos/genética , Predisposición Genética a la Enfermedad , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Contracción Muscular/fisiología , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/fisiología , Fuerza Muscular/fisiología , Músculo Esquelético/metabolismo , Músculo Esquelético/fisiología , Enfermedades Musculares/genética , Regeneración/genética , Regeneración/fisiología
7.
Br J Cancer ; 100(8): 1330-5, 2009 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-19367287

RESUMEN

Recent studies have suggested that activation of the EGFR pathway leads to malignant transformation only if the p53 protein is inactivated. Therefore, we evaluated the impact of TP53 mutations on cetuximab-based chemotherapy (CT) sensitivity in combination with KRAS mutations that have been associated with cetuximab resistance. KRAS and TP53 status were assessed in tumours from 64 metastatic colorectal cancer patients treated with cetuximab-based CT and correlated to clinical response using the Fisher's exact test. Times to progression (TTPs) according to gene status were calculated using the Kaplan-Meier method and compared with log-rank test. TP53 mutations were found in 41 patients and were significantly associated with controlled disease (CD), as defined as complete response, partial response or stable disease (P=0.037) and higher TTP (20 vs 12 weeks, P=0.004). Remarkably, in the subgroup of 46 patients without KRAS mutation, but not in patients with KRAS mutation, TP53 mutations were also associated with CD (P=0.008) and higher TTP (24 vs 12 weeks, P=0.0007). This study suggests that TP53 mutations are predictive of cetuximab sensitivity, particularly in patients without KRAS mutation, and that TP53 genotyping could have a clinical interest to select patients who should benefit from cetuximab-based CT.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos/uso terapéutico , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/genética , Mutación , Proteína p53 Supresora de Tumor/genética , Anciano , Sustitución de Aminoácidos , Anticuerpos Monoclonales Humanizados , Cetuximab , Neoplasias Colorrectales/patología , ADN de Neoplasias/genética , ADN de Neoplasias/aislamiento & purificación , Progresión de la Enfermedad , Relación Dosis-Respuesta a Droga , Exones , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Polimorfismo de Nucleótido Simple , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas p21(ras) , Proteínas ras/genética
9.
Br J Cancer ; 96(8): 1166-9, 2007 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-17375050

RESUMEN

The predictive value of KRAS mutation in metastatic colorectal cancer (MCRC) patients treated with cetuximab plus chemotherapy has recently been suggested. In our study, 59 patients with a chemotherapy-refractory MCRC treated with cetuximab plus chemotherapy were included and clinical response was evaluated according to response evaluation criteria in solid tumours (RECIST). Tumours were screened for KRAS mutations using first direct sequencing, then two sensitive methods based on SNaPshot and PCR-ligase chain reaction (LCR) assays. Clinical response was evaluated according to gene mutations using the Fisher exact test. Times to progression (TTP) were calculated using the Kaplan-Meier method and compared with log-rank test. A KRAS mutation was detected in 22 out of 59 tumours and, in six cases, was missed by sequencing analysis but detected using the SNaPshot and PCR-LCR assays. Remarkably, no KRAS mutation was found in the 12 patients with clinical response. KRAS mutation was associated with disease progression (P=0.0005) and TTP was significantly decreased in mutated KRAS patients (3 vs 5.5 months, P=0.015). Our study confirms that KRAS mutation is highly predictive of a non-response to cetuximab plus chemotherapy in MCRC and highlights the need to use sensitive molecular methods, such as SNaPshot or PCR-LCR assays, to ensure an efficient mutation detection.


Asunto(s)
Anticuerpos Monoclonales/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Colorrectales/genética , Receptores ErbB/antagonistas & inhibidores , Genes ras , Mutación , Anticuerpos Monoclonales Humanizados , Cetuximab , Neoplasias Colorrectales/tratamiento farmacológico , Humanos , Metástasis de la Neoplasia , Reacción en Cadena de la Polimerasa
10.
Sante Publique ; 17(2): 211-26, 2005 Jun.
Artículo en Francés | MEDLINE | ID: mdl-16001563

RESUMEN

HIV and AIDS prevention is part of the biology class curriculum in junior high and high school in both France and the Congo. The teachers must not only present the scientific knowledge but also try to incite and convince the students to adopt certain preventive behaviours in terms of their own personal conduct. This places the teachers in the domain of having a health promotion and education role. How do teachers perceive this new role? What objectives and outcome measures have they set, and what kind of educational method do they intend to use to achieve them? Based on interviews conducted in the year 2000 of 25 teachers (12 in France and 13 in Congo-Brazzaville), a profile has been defined for each teacher based on an analysis of his/her responses with regard to their role in terms of health education and more specifically in relation to AIDS prevention. A number of questions and concems emerged from this exercise, some of which were shared in common and others were clearly country-specific.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/prevención & control , Biología/educación , Conductas Relacionadas con la Salud , Educación del Paciente como Asunto , Servicios de Salud Escolar , Adolescente , Congo , Curriculum , Femenino , Francia , Humanos , Masculino , Evaluación de Programas y Proyectos de Salud
12.
Acta Physiol Scand ; 179(1): 75-84, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12940941

RESUMEN

AIM: The aim of this report is to show that eccentric exercise under well-controlled conditions is an alternative model, to chemical and mechanical analyses, and analyse the process of degeneration/regeneration in mouse soleus. METHODS: For this, mice were submitted to a single bout of eccentric exercise on a treadmill down a 14 degrees decline for 150 min and the soleus muscle was analysed at different times following exercise by histology and in situ hybridization in comparison with cardiotoxin-injured muscles. RESULTS: We analyse the regenerative process by detection of the accumulation of transcripts coding for the two myogenic regulatory factors, Myf-5 and MyoD, which are good markers of the activated satellite cells. From 24 h post-exercise (P-E), clusters of mononucleated Myf-5/MyoD-positive cells were detected. Their number increased up to 96 h P-E when young MyoD-positive myotubes with central nuclei began to appear. From 96 to 168 h P-E the number of myotubes increased, about 10-fold, the new myotubes representing 58% of the muscle cells (168 h P-E). CONCLUSION: These results show that this protocol of eccentric exercise is able to induce a drastic degeneration/regeneration process in the soleus muscle. This offers the opportunity to perform biochemical and molecular analyses of a process of regeneration without muscle environment defects. The advantages of this model are discussed in the context of fundamental and therapeutical perspectives.


Asunto(s)
Proteínas de Unión al ADN , Músculo Esquelético/fisiología , Esfuerzo Físico/fisiología , Regeneración , Transactivadores , Animales , Proteínas Cardiotóxicas de Elápidos , Modelos Animales de Enfermedad , Femenino , Ratones , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patología , Fibras Musculares Esqueléticas/fisiología , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Proteína MioD/metabolismo , Factor 5 Regulador Miogénico , Necrosis
13.
Protein Expr Purif ; 23(1): 121-7, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11570853

RESUMEN

This paper describes the overproduction and purification of the C-terminus polyhistidine-tagged outer membrane protein OprM, which is a part of the MexA-MexB-OprM active efflux system of Pseudomonas aeruginosa. Renaturation of the protein from inclusion bodies of Escherichia coli was achieved using guanidine-HCl as denaturing agent and n-octylpolyoxyethylene (C8POE) and n-octyltetraoxyethylene (C8E4) as nonionic detergents. The refolded protein was purified by ion-exchange and nickel-affinity chromatography. The final yield was 6 mg of pure histidine-tagged OprM per liter of E. coli culture. Renaturation was monitored by the effects of heating prior to SDS-PAGE, using a typical and exclusive property of outer membrane proteins. Immunoblotting revealed that the recombinant protein is addressed to the outer membrane of E. coli, after maturation by excision of its N-terminal signal sequence. Complementation of an oprM deletion mutant with the plasmid encoded histidine-tagged OprM protein restored antibiotic susceptibilities to wild-type levels, demonstrating functionality of recombinant OprM.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/biosíntesis , Proteínas Portadoras/biosíntesis , Clonación Molecular/métodos , Proteínas de Transporte de Membrana , Renaturación de Proteína , Marcadores de Afinidad , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/aislamiento & purificación , Proteínas Portadoras/genética , Proteínas Portadoras/aislamiento & purificación , Membrana Celular , Escherichia coli/genética , Escherichia coli/ultraestructura , Histidina , Calor , Cuerpos de Inclusión , Pliegue de Proteína , Pseudomonas aeruginosa/química , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación
14.
J Histochem Cytochem ; 49(7): 887-99, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11410613

RESUMEN

Given the importance of the myogenic regulatory factors (MRFs) for myoblast differentiation during development, the aims of this work were to clarify the spatial and temporal expression pattern of the four MRF mRNAs during soleus regeneration in mouse after cardiotoxin injury, using in situ hybridization, and to investigate the influence of innervation on the expression of each MRF during a complete degeneration/regeneration process. For this, we performed cardiotoxin injury-induced regeneration experiments on denervated soleus muscle. Myf-5, MyoD, and MRF4 mRNAs were detected in satellite cell-derived myoblasts in the first stages of muscle regeneration analyzed (2--3 days P-I). The Myf-5 transcript level dramatically decreased in young multinucleated myotubes, whereas MyoD and MRF4 transcripts were expressed persistently throughout the regeneration process. Myogenin mRNA was transiently expressed in forming myotubes. These results are discussed with regard to the potential relationships between MyoD and MRF4 in the satellite cell differentiation pathway. Muscle denervation precociously (at 8 days P-I) upregulated both the Myf-5 and the MRF4 mRNA levels, whereas the increase of both MyoD and myogenin mRNA levels was observed later, in the late stages of regeneration (30 days P-I). This significant accumulation of each differentially upregulated MRF during soleus regeneration after denervation suggests that each myogenic factor might have a distinct role in the regulatory control of muscle gene expression. This role is discussed in relation to the expression of the nerve-regulated genes, such as the nAChR subunit gene family. (J Histochem Cytochem 49:887-899, 2001)


Asunto(s)
Proteínas de Unión al ADN , Músculo Esquelético/inervación , Músculo Esquelético/metabolismo , Factores Reguladores Miogénicos/metabolismo , Regeneración , Transactivadores , Animales , Proteínas Cardiotóxicas de Elápidos , Femenino , Regulación de la Expresión Génica , Hibridación in Situ , Ratones , Desnervación Muscular , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Músculo Esquelético/fisiología , Proteína MioD/metabolismo , Factor 5 Regulador Miogénico , Factores Reguladores Miogénicos/genética , Miogenina , ARN Mensajero/metabolismo
17.
Cancer Res ; 60(11): 2760-3, 2000 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-10850409

RESUMEN

Large genomic deletions within the mismatch repair MLH1 and MSH2 genes have been identified in families with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, and their detection represents a technical problem. To facilitate their detection, we developed a simple semiquantitative procedure based on the multiplex PCR of short fluorescent fragments. This method allowed us to confirm in HNPCC families three known deletions of MLH1 or MSH2 and to detect in 19 HNPCC families, in which analysis of mismatch repair genes using classical methods had revealed no alteration, a deletion of exon 5 and a duplication of MSH2 involving exons 9 and 10. The presence of such duplications, the frequency of which is probably underestimated, must be considered in HNPCC families in which conventional screening methods have failed to detect mutations.


Asunto(s)
Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Reparación del ADN/genética , Proteínas de Unión al ADN , Eliminación de Gen , Duplicación de Gen , Proteínas de Neoplasias/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Adaptadoras Transductoras de Señales , Disparidad de Par Base/genética , Proteínas Portadoras , Exones , Salud de la Familia , Humanos , Intrones , Modelos Genéticos , Homólogo 1 de la Proteína MutL , Proteína 2 Homóloga a MutS , Proteínas Nucleares , Reacción en Cadena de la Polimerasa/métodos
18.
Mech Dev ; 94(1-2): 277-82, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10842087

RESUMEN

SPOCK is prevalent in developing synaptic fields of the central nervous system (Charbonnier et al., 2000. Mech. Dev. 90, 317-321). The expression of SPOCK during neuromuscular junction (NMJ) formation was compared to agrin and acetylcholine receptor (AChR) distribution. SPOCK is detected within the myogenic masses during the early steps of embryonic development, and distributed in the cytoplasm of myotubes before coclustering with AChRs. In the adult, SPOCK is present in axons and is highly expressed by Schwann cells. SPOCK altered expression pattern after nerve lesioning, or cholinergic transmission blockade, strongly indicate that its cellular distribution at the NMJ depends on innervation.


Asunto(s)
Músculo Esquelético/embriología , Unión Neuromuscular/embriología , Unión Neuromuscular/crecimiento & desarrollo , Proteoglicanos/genética , Proteoglicanos/metabolismo , Animales , Citoplasma/metabolismo , Regulación del Desarrollo de la Expresión Génica , Ratones , Ratones Endogámicos , Fibras Musculares Esqueléticas/fisiología , Proteoglicanos/inmunología , Ratas , Ratas Sprague-Dawley , Receptores Colinérgicos/metabolismo
19.
Carcinogenesis ; 21(4): 563-5, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10753186

RESUMEN

Somatic mutations of the tumor suppressor gene p53 have been frequently detected in esophagal cancers, but their biological significance remains to be established. The tumor suppressor activity of p53 results in part from its ability to transactivate genes involved in the cell cycle and apoptosis, such as p21, bax and PIG3, and some p53 mutations may have a differential effect on the transactivation of these target genes. We developed yeast strains in which the activation by wild-type p53 of reporter plasmids containing p53 binding sites present within these target genes induces a change in the color of the colonies (red/white). Using these strains, we analyzed 56 esophageal cancers from patients residing in Normandy, France, a high incidence geographic area. Forty-seven tumors (84%), scored as mutant with the p21, bax and PIG3 reporter strains and in most of the cases (76%), the percentage of red colonies suggested that both p53 alleles were inactivated. Sequencing analysis allowed the identification of a p53 mutation in each positive sample, and the spectrum of mutations was in agreement with the etiological role of tobacco and alcohol. These results confirm the high frequency of biallelic p53 mutations in esophageal carcinoma and strongly suggest that their biological consequence is the complete alteration of the transactivation of genes involved in the cell cycle and apoptosis, which indicates that p53 alteration is a key event in esophagus carcinogenesis.


Asunto(s)
Apoptosis , Neoplasias Esofágicas/genética , Regulación Neoplásica de la Expresión Génica , Genes p53 , Mutación , Ciclo Celular , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/genética , Humanos
20.
Mech Dev ; 90(2): 317-21, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10640720

RESUMEN

SPOCK is a modular proteoglycan, with homology with proteins involved in cell adhesion processes and neurogenesis. We have previously shown that SPOCK transcripts predominate in the adult mouse brain. Here, we report its expression during mouse embryonic development by in situ hybridization, and immunocytochemistry. SPOCK is actively expressed at the onset of neurogenesis during periods of neuron migration and axonal outgrowth. At a later developmental stage, its expression is particularly prevalent within developing synaptic fields. In the peripheral nervous system, SPOCK expression is also developmentally regulated particularly in dorsal root ganglion neurons.


Asunto(s)
Desarrollo Embrionario y Fetal , Proteoglicanos/genética , Animales , Expresión Génica , Ratones , Sistema Nervioso/embriología , Proteoglicanos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA